» Articles » PMID: 33182497

Ketamine and Calcium Signaling-A Crosstalk for Neuronal Physiology and Pathology

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Nov 13
PMID 33182497
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Ketamine is a non-competitive antagonist of NMDA (N-methyl-D-aspartate) receptor, which has been in clinical practice for over a half century. Despite recent data suggesting its harmful side effects, such as neuronal loss, synapse dysfunction or disturbed neural network formation, the drug is still applied in veterinary medicine and specialist anesthesia. Several lines of evidence indicate that structural and functional abnormalities in the nervous system caused by ketamine are crosslinked with the imbalanced activity of multiple Ca-regulated signaling pathways. Due to its ubiquitous nature, Ca is also frequently located in the center of ketamine action, although the precise mechanisms underlying drug's negative or therapeutic properties remain mysterious for the large part. This review seeks to delineate the relationship between ketamine-triggered imbalance in Ca homeostasis and functional consequences for downstream processes regulating key aspects of neuronal function.

Citing Articles

Treadmill Exercise Training Ameliorates Apoptotic Cells and DNA Oxidation in the Cerebral Cortex of Rats Exposed to Chronic Ketamine Abuse.

Sabziparvar S, Khodaei K, Azar J Addict Biol. 2025; 30(3):e70025.

PMID: 40062767 PMC: 11892017. DOI: 10.1111/adb.70025.


Abdominal Pain and Dysuria Secondary to Chronic Recreational Ketamine Use: A Case Report on K-cramps.

Boccio E, Haidar J, Thiefault M, Lutwak N, Kohen B, Atia H Cureus. 2025; 17(2):e78422.

PMID: 40046349 PMC: 11881789. DOI: 10.7759/cureus.78422.


DSP-6745, a novel 5-hydroxytryptamine modulator with rapid antidepressant, anxiolytic, antipsychotic and procognitive effects.

Kitaichi M, Kato T, Oki H, Tatara A, Kawada T, Miyazaki K Psychopharmacology (Berl). 2024; 241(11):2223-2239.

PMID: 38856765 DOI: 10.1007/s00213-024-06629-2.


Ketamine: Pro or antiepileptic agent? A systematic review.

Shehata I, Kohaf N, ElSayed M, Latifi K, Aboutaleb A, Kaye A Heliyon. 2024; 10(2):e24433.

PMID: 38293492 PMC: 10826813. DOI: 10.1016/j.heliyon.2024.e24433.


Targeting CaN/NFAT in Alzheimer's brain degeneration.

Mackiewicz J, Lisek M, Boczek T Front Immunol. 2023; 14:1281882.

PMID: 38077352 PMC: 10701682. DOI: 10.3389/fimmu.2023.1281882.


References
1.
Adesnik H, Li G, During M, Pleasure S, Nicoll R . NMDA receptors inhibit synapse unsilencing during brain development. Proc Natl Acad Sci U S A. 2008; 105(14):5597-602. PMC: 2291097. DOI: 10.1073/pnas.0800946105. View

2.
de Faria Jr O, Gonsalvez D, Nicholson M, Xiao J . Activity-dependent central nervous system myelination throughout life. J Neurochem. 2018; 148(4):447-461. PMC: 6587454. DOI: 10.1111/jnc.14592. View

3.
Yoshii A, Constantine-Paton M . Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease. Dev Neurobiol. 2010; 70(5):304-22. PMC: 2923204. DOI: 10.1002/dneu.20765. View

4.
Phoumthipphavong V, Barthas F, Hassett S, Kwan A . Longitudinal Effects of Ketamine on Dendritic Architecture In Vivo in the Mouse Medial Frontal Cortex. eNeuro. 2016; 3(2). PMC: 4819286. DOI: 10.1523/ENEURO.0133-15.2016. View

5.
Alves V, Alves-Silva H, Orts D, Ribeiro-Silva L, Arcisio-Miranda M, Oliveira F . Calcium Signaling in Neurons and Glial Cells: Role of Cav1 channels. Neuroscience. 2019; 421:95-111. DOI: 10.1016/j.neuroscience.2019.09.041. View